[1. Aggarwal S, Kramer D, Yonas H, Obrist W, Kang Y, Martin M, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology. 1994; 19:80-7.10.1002/hep.1840190114]Open DOISearch in Google Scholar
[2. Hazell AS, Butterworth RF. Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc Soc Exp Biol Med. 1999; 222:99-112.10.1046/j.1525-1373.1999.d01-120.x]Search in Google Scholar
[3. Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003; 96:623-33.10.1093/qjmed/hcg110]Search in Google Scholar
[4. Shawcross D, Jalan R. The pathophysiologic basis of hepatic encephalopathy: central role for ammonia and inflammation. Cell Mol Life Sci. 2005; 62:2295-304.10.1007/s00018-005-5089-0]Open DOISearch in Google Scholar
[5. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev. 1987; 67:440-519.10.1152/physrev.1987.67.2.440]Search in Google Scholar
[6. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003; 125:755-64.10.1016/S0016-5085(03)01051-5]Search in Google Scholar
[7. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004; 40: 247-54.10.1016/j.jhep.2003.10.01614739095]Open DOISearch in Google Scholar
[8. Rolando N, Wade J, Davalos M, Wendon J, Philpott- Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology. 2000; 32:734-9.10.1053/jhep.2000.1768711003617]Open DOISearch in Google Scholar
[9. Chu CJ, Wang SS, Lee FY, Chang FY, Lin HC, Hou MC, et al. Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamideinduced fulminant hepatic failure. Eur J Clin Invest. 2001; 31:156-63.10.1046/j.1365-2362.2001.00775.x11168455]Open DOISearch in Google Scholar
[10. Zimmermann C, Ferenci P, Pifl C, Yurdaydin C, Ebner J, Lassmann H, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology. 1989; 9:594-601.10.1002/hep.18400904142564368]Open DOISearch in Google Scholar
[11. Reddy PV, Murthy C, Reddanna P. Fulminant hepatic failure induced oxidative stress in nonsynaptic mitochondria of cerebral cortex in rats. Neurosci Lett. 2004; 368:15-20.10.1016/j.neulet.2004.06.046]Search in Google Scholar
[12. Swapna I, Kumar KV, Reddy PV, Murthy C, Reddanna P, Senthilkumaran B. Phospholipid and cholesterol alterations accompany structural disarray in myelin membrane of rats with hepatic encephalopathy induced by thioacetamide. Neurochem Int. 2006; 49:238-44.10.1016/j.neuint.2006.01.012]Search in Google Scholar
[13. Norton NS, McConnell JR, Rodriguez-Sierra JF. Behavioral and physiological sex differences observed in an animal model of fulminant hepatic encephalopathy in the rat. Physiol Behav. 1997; 62:1113-24.10.1016/S0031-9384(97)00267-9]Open DOISearch in Google Scholar
[14. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature. 2001; 413:527-31.10.1038/35097089]Search in Google Scholar
[15. Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol. 1993; 231:313-4.10.1016/0014-2999(93)90468-W]Search in Google Scholar
[16. Zhan C, Yang J. Protective effects of isoliquiritigenin in transient middle cerebral artery occlusion-induced focal cerebral ischemia in rats. Pharmacol Res. 2006; 53:303-9.10.1016/j.phrs.2005.12.00816459097]Search in Google Scholar
[17. Schnur J, Olah J, Szepesi A, Nagy P, Thorgeirsson SS. Thioacetamide-induced hepatic fibrosis in transforming growth factor beta-1 transgenic mice. Eur J Gastroenterol Hepatol. 2004; 16:127-33.10.1097/00042737-200402000-0000215075984]Open DOISearch in Google Scholar
[18. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. Hepatology. 2002; 36:12-21.10.1053/jhep.2002.3368412085344]Open DOISearch in Google Scholar
[19. Chu CJ, Chen CT, Wang SS, Lee FY, Chang FY, Lin HC, et al. Hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure: role of endotoxin and tumor necrosis factor-alpha. Zhonghua Yi Xue Za Zhi (Taipei). 2001; 64:321-30.]Search in Google Scholar
[20. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology. 1992; 15:1060-6.10.1002/hep.18401506151592344]Open DOISearch in Google Scholar
[21. Maness LM, Kastin AJ, Farrell CL, Banks WA. Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology. 1998; 139:4556-62.10.1210/endo.139.11.63199794465]Search in Google Scholar